COMMON MAPS
Map version new-york activity top-down
Main site Contact
Menu
↑ parent activity group ·
research dossier

KEYSTONE FOR INCUBATING INNOVATION IN LIFE SCIENCES NETWORK (KIILN) INC
NEW YORK, NY · EIN 464938122 · Form 990EZ · FY2024 · Micro (<$100K)
revenue
$0
expenses
$22K
net assets
$0
employees
—
mission · from form 990

THE PRIMARY PURPOSE OF KIILN IS TO FOSTER SCIENTIFIC RESEARCH OF BIOTECHNOLOGY COMPANIES FOCUSED ON MEDICAL ADVANCES INCLUDING THE DEVELOPMENT OF NEW TECHNIQUES, DEVICES AND CURES/TREATMENTS FOR DISEASE, AND TO PROVIDE RESOURCES TO SUPPORT THE NEW YORK BIOTECHNOLOGY INNOVATION COMMUNITY TO DEVELOP INNOVATIONS COMMERCIALLY FOR PUBLIC BENEFIT.

profile · synthesized from sources

Keystone for Incubating Innovation in Life Sciences Network (KIILN) supports biotechnology companies focused on medical advances, including new treatments, devices, and cures for disease. The organization provides resources to foster scientific research and commercial development within the New York biotechnology innovation community. Its primary purpose is to advance public benefit through science and technology innovation in life sciences.

named programs · 1 · from sources

What they call their work

Biotechnology Innovation Support Program
Provides resources and research support to biotechnology companies in New York focused on medical advances, including development of new techniques, devices, and treatments for disease
activities · 2 groups

What they do

  • Medical Research Funding 1 activity
    • Fostering scientific research in biotechnology for medical advances
      Supports biotechnology companies in conducting scientific research aimed at medical advances, including the development of new techniques, devices, and cures or treatments for diseases.
  • Research Facility Management 1 activity
    • Providing resources to support commercial development of biotech innovations
      Offers resources to the New York biotechnology innovation community to advance the commercial development of innovations for public benefit.
financials · form 990EZ · fy2024
revenue
Total revenue$0
Contributions & grants$0—
Program service revenue——
Investment income——
Other revenue—
expenses
Total expenses$22K
Program expenses—
Admin / overhead—
Fundraising—
Salaries & benefits—
Grants paid out$20K
balance sheet
Total assets$0
Cash—
Investments—
Liabilities—
Net assets$0
5 years on record · 2020–2024
leadership · form 990 part vii · fy2024

Who runs it

board members · 5
  • GABRIELLA CASALENA — DIRECTOR
  • ILSE DAEHN — DIRECTOR
  • MERINA VARGHESE — DIRECTOR
  • NICOLE MCKNIGHT — DIRECTOR
  • YANA ZORINA — DIRECTOR
strategies · 1

How they approach the work

Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.

  • Research and Development Support
    methodology: research_and_development_support
    By funding and resourcing early-stage biotechnology research, we accelerate the development of medical advances and their translation to market, because access to capital and infrastructure reduces barriers to innovation and increases the likelihood of successful commercialization.